Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


爱加速最新破解版-旋风加速度器

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

爱加速最新破解版-旋风加速度器

爱加速最新破解版-旋风加速度器

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

爱加速最新破解版-旋风加速度器

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
hd2.0ne加速器  老王vnp2.2.25蓝奏云  锤子加速器  闪飞加速器官网  旋风加速度器,旋风加速度器苹果版,旋风加速npv下载,旋风永久免费加速器,旋风加速安卓,旋风加速器官网下载  加速器国外npv,加速器国外vqn,加速器国外打不开,加速器国外vp